Your browser doesn't support javascript.
loading
COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran, Wilfredo F; Lam, Evan C; Astudillo, Michael G; Yang, Diane; Miller, Tyler E; Feldman, Jared; Hauser, Blake M; Caradonna, Timothy M; Clayton, Kiera L; Nitido, Adam D; Murali, Mandakolathur R; Alter, Galit; Charles, Richelle C; Dighe, Anand; Branda, John A; Lennerz, Jochen K; Lingwood, Daniel; Schmidt, Aaron G; Iafrate, A John; Balazs, Alejandro B.
Afiliación
  • Garcia-Beltran WF; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Lam EC; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Astudillo MG; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Yang D; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Miller TE; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Feldman J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Hauser BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Caradonna TM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Clayton KL; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Nitido AD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Murali MR; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Charles RC; Infectious Disease Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Dighe A; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Branda JA; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Lennerz JK; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Lingwood D; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Schmidt AG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Balazs AB; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: abalazs@mgh.harvard.edu.
Cell ; 184(2): 476-488.e11, 2021 01 21.
Article en En | MEDLINE | ID: mdl-33412089
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores / Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cell Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores / Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cell Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos